先端医療推進機構が運営する治験審査委員会(JAPSAM-IRB)は、医療機関内に設置された従来型のIRBとは異なる第三者機関としての審査委員会です。
多施設共同治験に対する一括審査も受託可能です。
The Institutional Review Board operated by the Japanese Association for the Promotion of State of the Art in Medicine (JAPSAM-IRB) is a third-party IRB that differs from conventional IRBs established within medical institutions. We can also undertake comprehensive reviews for multi-center clinical trials.
Characteristics of JAPSAM-IRB
- As a third-party organization, we conduct fair, neutral and transparent reviews
- Regular review committee meetings are held (in principle, once a month)
- Efficient and prompt response through standardization of various review documents, simplification of review procedures and centralized management
- Undertakes review cases for a variety of disease areas
- Committee reviews composed of members with a wide range of expertise